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Abstract
Aim: The purpose of this study was to compare the electrocardiographic (ECG), hematological and clinico-biochemical 
effects of two balanced anesthetic protocols in dogs.
Materials and Methods: A total of 20 clinical cases of dogs, randomly divided into two groups of 10 animals each 
were made part of study. All dogs were premedicated with injection atropine sulfate @ 0.04 mg/kg body weight (b. wt.) 
subcutaneously followed 15 min later with injection butorphanol tartarate @ 0.2 mg/kg b. wt. intravenous (IV). Subsequently 
after 10 min premedicated with injection diazepam @ 0.5 mg/kg b. wt. IV (Group DP) or injection acepromazine maleate 
@ 0.015 mg/kg b. wt. IV (Group AP) followed by injection propofol “till effect” IV for induction of surgical anesthesia. 
The animals were immediately transferred to halothane in oxygen. Observations recorded in dogs included ECG recordings, 
hematological and clinico-biochemical observations at various time intervals.
Results: No arrhythmia was observed in any animal pre-operatively and intra-operatively in any of the groups. Significant 
fall in packed cell volume (PCV) and total erythrocyte count occurred in DP group in early phase, whereas only PCV 
decreased significantly in AP group. Biochemical parameters were non-significant in both the groups.
Conclusion: Both diazepam-butorphanol-propofol-halothane and acepromazine-butorphanol-propofol-halothane are safe 
with respect to their ECG, hematological and biochemical effects in clinical cases.
Keywords: acepromazine, butorphanol, diazepam, dog, propofol.
Introduction
Small animals are most often placed under gen-
eral anesthesia due to the types of procedures typically 
performed, the small size of the patient, their suitabil-
ity to general anesthesia, and the greater degree of 
control. A balanced anesthesia protocol can be used 
whereby different drugs with different effects are used 
and hence that a high dose of just one drug can be 
avoided. Premedication plays an important role in this 
respect, because analgesic and myorelaxant effects of 
substances used for premedication may have prime 
importance for the whole anesthesia. The combination 
of complementary drugs permits use of a decreased 
dose of each drug to achieve anesthesia and decreases 
their commensurate side effects. These requirements 
are often met when neuroleptanalgesic combinations 
– The combination of a neuroleptic drug with seda-
tive properties and an opioid analgesic drug are used. 
Combinations of diazepam-butorphanol and aceprom-
azine-butorphanol are routinely used as preanesthetic 
to general anesthesia in dogs.
Propofol is one of the most common anesthetics 
used in present-day medicine [1]. Propofol is also a 
reliable, safe and prompt anesthetic agent when used 
during induced cardiovascular and pulmonary-im-
paired conditions without surgery, or to induce anes-
thesia prior to inhalant anesthesia with and without 
surgery. In addition, the drug has antioxidant prop-
erties (propofol-nitrous oxide) secondary to its phe-
nol-based chemical structure [2]. Halothane (2-bro-
mo-2-chloro-1,1,1-trifluoroethane), a halogenated 
hydrocarbon, is an inhalational anesthetic agent that 
has been widely used as an induction and mainte-
nance volatile anesthetic since introduced into clinical 
practice in 1957 [3]. Halothane anesthesia has been 
reported to be possibly the most commonly used inha-
lational anesthetic in many developing countries [4].
Several drugs used in anesthesia interfere with 
the cardiac rhythm. As a rule, those effects of the 
anesthetics on the cardiac conduction system, such as 
those promoted by drugs like acetylcholine or opioids 
are well known. On the other hand, careful studies on 
more recent drugs are lacking and their effects are not 
completely understood [5]. Both anesthetic drugs and 
surgical procedure have variety of effects on blood 
hemato-biochemistry. These alterations are particu-
larly important in clinical patients which may have 
underlying conditions.
Keeping in view the above, the goal of this 
study was to clinically evaluate electrocardiographic 
(ECG), hematological and clinico-biochemical effects 
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of diazepam and acepromazine along with butorpha-
nol in propofol induction and halothane maintenance 
anesthesia as balanced anesthesia protocol in canines.
Materials and Methods
Ethical approval
The research program was conducted after the 
approval of the Institutional Animal Ethics Committee, 
CSKHPKV, Palampur (H.P).
Location and Clinical programme of work
Clinical cases of dogs of either sex presented to 
the Teaching Veterinary Clinical Complex of the col-
lege for various surgical affections were made the sub-
jects of the study. The dogs were subjected to a detailed 
physical examination and were categorized accord-
ing to surgical procedures performed and American 
Society of Anesthesiologists Classifications (Table-1). 
The area of saphenous and recurrent tarsal veins in all 
the limbs were prepared aseptically for administration 
of drugs as well as for collection of blood samples 
along with intravenous (IV) catheterization, deliver-
ing injection ringer lactate. All dogs were premedi-
cated with injection. Atropine sulfate @ 0.04 mg/kg 
body weight (b. wt.) followed 15 min later with injec-
tion butorphanol tartarate @ 0.2 mg/kg b. wt IV. 
Subsequently after 10 min pre-medicated with injec-
tion diazepam @ 0.5 mg/kg b. wt IV (Group DP, n=10) 
or injection. acepromazine maleate @ 0.015 mg/kg 
b.wt. IV (Group AP, n=10). After 5 min anesthesia was
induced with injection. Propofol (3.0-5.0 mg/kg) by 
IV injection “till effect.” Then endotracheal intubation 
was done and animals were connected to the anesthetic 
machine (co-axial circuit with carbon dioxide absorber 
[Anesthetic machine: Moduflex co-axial Circuit, 
Dispomed Ltd. Canada]) with halothane vaporizer till 
the end of surgery. Oxygen flow rates were set accord-
ing to b. wt. of the animal. The groups were evaluated 
on the basis of the following parameters: ECG, hema-
tological and biochemical observations.
ECG observations
Animals were positioned on a non-conductive 
surface in right lateral recumbency with forelimbs 
perpendicular to the long axis of the body. ECG was 
obtained using lead II system (1 mv=1 cm 25 mm/s). 
The animals were monitored by continued computer-
ized ECG using multi parameter monitor (BPL India, 
Ltd., New Delhi, India). ECG tracings were taken at 
regular time intervals i.e., T0 min (min), T1 min, T5 min, 
T15 min, T30 min and T45 min (Table-2). Development of 
arrhythmias were observed and following time and 
voltage function components of ECG were recorded 
from tracings: P interval, QRS interval, QT interval, 
T interval, ST segment elevation and depression from 
base line, PR segment, P amplitude, R amplitude, 
QRS amplitude, T amplitude.
Hematological observations
The blood samples collections were made at 
base line, early phase and late phase as per Table-3. 
To evaluate hematological parameters, venous 
blood (0.5-1 ml) of each animal was collected in 
EDTA vials. The hematological parameters esti-
mated were hemoglobin (Hb), packed cell volume 
(PCV), total erythrocyte count (TEC). The samples 
were analyzed using blood cell counter (Blood Cell 
Counter: BC-2800 vet, Auto Hematology Analyzer, 
Mindray).
Biochemical observations
A volume of 5 ml of venous blood was collected 
in heparinized vials. Plasma was separated by cen-
trifugation at 2500 rpm for 15 min. The blood glu-
cose was estimated immediately by digital glucom-
eter (Blood Glucose Monitor: Bayer contour, Bayer 
AG). The various plasma attributes and enzymes 
estimated were: Aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), blood urea nitro-
gen (BUN), creatinine (CRTN), total protein (TPR)
and alkaline phosphatase and plasma chloride using 
Table-1: Patient classification.
DP group AP group
Signalment
Mean age (months) 25.5±4.63 29.00±8.83
Gender
Male 2 7
Female 8 3
Mean b.wt (kg) 14.58±2.01 17.99±1.50
Categorized surgical 
procedures
Elective surgeries 9 6
Orthopedic surgeries 1 2
Tumor excision - 1
Others - 1
Physical status
ASA 1 9 6
ASA 2 - 3
ASA 3 1 1
Total 10 10
b.wt=Body weight, ASA=American Society of 
Anesthesiologists
Table-2: Time interval for recording various observations.
Time interval Time/stage
T0 Base value (before administration 
of anesthetic drug)
T1 Just after induction and start of 
halothane maintenance
T5 5 min post halothane
T15 15 min post halothane
T30 30 min post halothane
T45 45 min post halothane
Table-3: Time interval for hemato-biochemical 
observations.
Time interval Time/stage
Base line Base value (before anesthesia)
Early phase Intraoperative (at T30 i.e., 
30 min post halothane)
Late phase Post-operative (after extubation)Available at www.veterinaryworld.org/Vol.7/October-2014/16.pdf
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commercially available kits on semi-automatic blood 
chemistry analyzer (Blood Chemistry Analyzer: 
(RA-50), Bayer Diagnostics, Gujarat-India). Plasma 
sodium and potassium (K) were estimated on flame 
photometer (Flame Photometer: Flame Photometer 
129, Systronics, Gujarat-India).
Statistical analysis
The statistical analysis of data was performed 
with SAS 9.2 by SAS Institute Inc., Cary. NC. USA, 
using simple t-test. The paired t-test was used to com-
pare the mean values at different intervals with their 
base values in each group. p<0.05 and p<0.01 were 
considered as significant.
Results
ECG effects
The ECG parameters during anesthesia in both 
the groups are depicted in Tables-4 and 5. No arrhyth-
mia was observed in any animal pre-operatively and 
intra-operatively in any of the groups. There was sig-
nificant increase in QT interval at T15 (p<0.05), T30 
(p<0.05) and at T45 (p<0.01) in AP group. Significant 
(p<0.05) increase in P amplitude was recorded just 
after induction in AP group. Furthermore, significant 
(p<0.05) increase in PR segment was recorded at 
T30 in AP group. In one animal in DP group, wan-
dering sinus pacemaker was present at T1 and T5 
(Figure-1a-c). Diphasic T waves were also present in 
this dog after induction until the end of the anesthetic 
period. ST elevation was noticed in an animal in AP 
group, 5 min after induction and start of halothane 
maintenance, which sustained till T45 (Figure-1d 
and e). Generally spiked hyperkalemic T waves 
were noticed in another dog in AP group (Figure-1f 
and g). T waves at T0 and T5 were normal, while at 
T15, T30 and T45 peaked T waves were present. Plasma 
potassium levels in this dog were; before anesthesia 
4.0 mmol/L, during anesthesia 7.0 mmol/L and after 
anesthesia 7.0 mmol/L.
Hematological and biochemical observations
In both the groups, there was non-significant fall 
in Hb in early phase which later recouped but values 
were lower than the base line (Table-6). There was 
significant fall in PCV at early phase in both the groups 
with (p<0.01) in DP and (p<0.05) in AP group respec-
tively. Similarly TEC showed significant decrease at 
early phase (p<0.01) and late phase (p<0.05) in DP 
group. All the changes were within clinically normal 
ranges. Inter group comparison showed non-signifi-
cant difference between values of Hb, PCV and TEC.
Mean±standard error values of biochemical 
observations in both the groups at different time inter-
vals are illustrated in Table-7. During the present study, 
in general, the changes in biochemical parameters 
were observed to be non-significant. Glucose showed 
non-significant decrease from base line values in both 
the groups at early phase. At late phase glucose lev-
els increased non-significantly in comparison to early 
phase. There was non-significant decrease in AST 
in both the groups and ALT in DP group. Intergroup 
comparison showed significant (p<0.05) difference 
between late phase values of TPR. Significant differ-
ence (p<0.05) was also found in CRTN early phase 
values and late phase (p<0.01). Chloride values were 
also significant (p<0.05) at early phase between two 
groups.
Discussion
This clinical study was carried out to clarify and 
compare the degree of influence of anesthetic agents 
commonly used during anesthesia on the heart con-
duction systems of dogs, with or without the presence 
of ECG changes in the pre-anesthetic ECG. Effects 
on blood hematology and biochemistry were also 
observed. A total of twenty animals were randomly 
and equally divided into two groups DP and AP of 
10 animals each.
ECG was overall normal in both the groups and 
significance cannot be attached to some of the changes 
in time and voltage parameters of ECG. Wandering 
sinus pacemaker is a frequent normal finding in 
dogs [6]. Diphasic T waves in the animal correlated 
with intraoperative hypokalemia [6]. Plasma potas-
sium levels in this dog were; base line 6.0 mmol/L, 
early phase 3.3 mmol/L and late phase 3.6 mmol/L. 
Reference ranges for canine plasma potassium are 
3.6-6.0 mmol/L [7]. Anesthetic induced myocardial 
Table-4: Mean±SE values of ECG variables during anesthesia in group DP (n=10) and AP (n=10) at different time 
intervals in dogs.
Time 
interval 
(min)
P interval (s) QRS interval (s) QT interval (s) T interval (s)
DP AP DP AP DP AP DP AP
T0 0.04±0.001 0.047±0.005 0.058±0.006 0.051±0.002 0.172±0.017 0.181±0.008 0.056±0.006 0.058±0.007
T1 0.043±0.002 0.047±0.003 0.054±0.003 0.049±0.002 0.168±0.018 0.180±0.005 0.051±0.005 0.065±0.005
T5 0.044±0.003 0.047±0.003 0.056±0.003 0.052±0.003 0.200±0.010 0.197±0.007 0.064±0.007 0.076±0.010
T15 0.043±0.001 0.057±0.003 0.052±0.003 0.050±0.002 0.198±0.006 0.202a±0.005 0.063±0.007 0.064±0.011
T30 0.04±0.001** 0.05±0.003 0.054±0.003 0.047±0.002 0.219±0.010 0.215a±0.008 0.060±0.009 0.080±0.01
T45 0.038±0.002** 0.055±0.004 0.056±0.002 0.055±0.004 0.203±0.007 0.217ab±0.007 0.068±0.012 0.080±0.008
aThe mean difference from base value is significant (p<0.05), abThe mean difference from base value is 
significant (p<0.01), **The mean difference between the groups is significant (p<0.01), SE=Standard error, 
ECG=ElectrocardiographicAvailable at www.veterinaryworld.org/Vol.7/October-2014/16.pdf
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hypoxia may have caused ST elevation [6]. Marked 
ST-segment elevation in the right precordial leads 
in propofol anesthesia has been reported in humans 
too [1]. Spiked T waves may have been caused by 
intraoperative hyperkalemia [6]. Plasma potassium 
levels in this dog were; before anesthesia 4.0 mmol/L, 
during anesthesia 7.0 mmol/L and after anesthesia 
7.0 mmol/L. Spiked T waves and biphasic T waves 
were also observed in xylazine-propofol anesthesia in 
dogs [8].
Prolonged QT interval can occur in hypother-
mia and bradycardia [6]. There is inverse relationship 
between QT interval and heart rate [9,10]. Similarly, 
propofol induced increase in the means of PQ, QRS 
and QT intervals with decrease in heart rate and 
arterial blood pressure were observed in dogs [11], 
whereas decrease in QT interval has been reported in 
goats [12]. Dennis et al. [13] compared the effects of 
propofol and thiopentone on ECG of dogs and found 
that propofol induced a comparatively lesser increase 
in QT and ST intervals. Furthermore, halothane has 
been reported to prolong QT interval in humans [14]. 
Therefore, increase in QT interval in present study may 
have been due to bradycardia, anesthetic caused hypo-
thermia or propofol and halothane caused increase.
Decrease in Hb intra-operatively may be 
because whether or not animals are anemic prior to 
the operative procedure, Hb concentrations will be 
decreased intraoperatively by anesthetic-induced 
vasodilation, splenic dilation, non-Hb-containing 
fluid administration and blood loss [7]. Similarly, 
Naghibi et al. [15] reasoned that due to vasodila-
tion at the level of microcirculation and passage of 
many red blood cell (RBC’s) from circulation may 
cause decrease in Hb level measured in peripheral 
veins, which is also called as plasma skimming. 
Pooling of circulatory blood cells in the spleen or 
other reservoirs secondary to sympathetic activity 
may explain the decrease in Hb, PCV and total leu-
kocyte count [16].
Figure-1: Electrocardiographic findings, (a) At T0 normal electrocardiographic, normal P waves and T waves, (b) At T5 
wandering sinus pacemaker (black arrows) is evident and diphasic T waves (blue arrows), (c) At T15 absence of wandering 
sinus pacemaker and diphasic T waves are still presented, (d) Normal ST segment at T0, (e) At T5 elevation in ST segment 
was observed (black arrows), (f) At T0 normal T waves, (g) At T15 typically spiked hyperkalemic T waves present (black 
arrows).
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Results of this study are in consistence with 
previous studies. Gill et al. [17] reported decrease in 
hematocrit, Hb and RBC count values and an increase 
in white blood cell count values after surgery was 
performed under acetylpromazine-propofol anesthe-
sia in dogs. Similarly, decrease in Hb, PCV and TEC 
has been reported in diazepam-propofol anesthesia in 
dogs [18]. Whereas, no change in PCV and a decrease 
in Hb, TEC and TLC till 15th min after induction 
of anesthesia with propofol and then a gradual rise 
towards the pre induction levels was observed [19]. 
Halothane induced significant decrease in PCV, Hb 
and plasma protein was also observed in dogs [20]. 
Thus combined effects of propofol, halothane with 
anesthetic induced change may have decreased Hb, 
PCV and TEC in the present study.
Hypoglycemia may have occurred as a non-spe-
cific hormonal response to the stress of anesthesia 
and operation [7]. Previous studies have reported 
hyperglycemia with use of propofol [21]. There were 
no deleterious effects of halothane on liver transami-
nases in this study rather AST values decreases intra-
operatively. Kwon et al. [22] observed decrease in 
AST and ALT values within clinically normal range 
and non-significant change in BUN and CRTN levels 
during propofol anesthesia in dogs, when propofol 
anesthesia was induced and maintained for 7 con-
secutive days in dogs. No alterations in biochemical 
parameters (except hyperglycemia) in dogs under 
propofol anesthesia have been published by Mukati 
et al. [21]. Halothane or its metabolites could cause 
a mild increase in liver enzymes suggestive of 
sub-clinical liver cell alteration which buttresses the 
fact that halothane anesthesia is still a safe agent in 
patients without pre-existing liver disease. Halothane 
induced elevation in serum liver enzymes have been 
reported in dogs [23], in camels [24]. Better blood 
supply to liver due to propofol administration may 
have caused decrease in ALT and AST as observed 
in this study.
In the present study, there was no significant dif-
ference in plasma electrolyte concentrations during 
propofol-halothane anesthesia in all groups, which 
indicated that electrolyte balance is not altered. 
Halothane has been reported not to cause any sig-
nificant alteration in the level of plasma sodium and 
potassium in buffaloes also [25].
Conclusion
Both the anesthetic combinations i.e., diaz-
epam-butorphanol-propofol-halothane and acep 
romazine-butorphanol-propofol-halothane pro-
duced no arrhythmia. Prolongation of QT inter-
val was observed in AP group, however it is clini-
cally acceptable. Significant fall in PCV and TEC 
occurred in DP group in early phase, whereas only 
PCV decreased significantly in AP group. These 
changes were within clinically normal ranges. No 
significant biochemical changes were observed. Available at www.veterinaryworld.org/Vol.7/October-2014/16.pdf
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Thus, both combinations are safe with respect to 
their ECG, hematological and biochemical effects 
in clinical cases.
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